GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Beginning Cash Position

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Beginning Cash Position : $17.37 Mil (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Beginning Cash Position?

China SXT Pharmaceuticals's Beginning Cash Position for the quarter that ended in Sep. 2023 was $17.37 Mil.

China SXT Pharmaceuticals's quarterly Beginning Cash Position declined from Sep. 2022 ($15.57 Mil) to Mar. 2023 ($2.98 Mil) but then increased from Mar. 2023 ($2.98 Mil) to Sep. 2023 ($17.37 Mil).

China SXT Pharmaceuticals's annual Beginning Cash Position increased from Mar. 2021 ($7.29 Mil) to Mar. 2022 ($13.36 Mil) and increased from Mar. 2022 ($13.36 Mil) to Mar. 2023 ($15.57 Mil).

China SXT Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for China SXT Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Beginning Cash Position Chart

China SXT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Beginning Cash Position
Get a 7-Day Free Trial 0.66 9.29 7.29 13.36 15.57

China SXT Pharmaceuticals Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.36 0.03 15.57 2.98 17.37

China SXT Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

China SXT Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Beginning Cash Position
Comparable Companies
CSUI HCANF CPHI MJNE KGKG MNKTQ VFRM STMH KAYS NXEN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
2RY0:Germany
Address
No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
Website
http://www.sxtchina.com
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.